苄基-(3-甲基-异恶唑-5-基甲基)-胺，CAS 登记号 154016-55-4，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于染料及颜料。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
染料及颜料
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 苄基-(3-甲基-异恶唑-5-基甲基)-胺 的 CAS 号：154016-55-4，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及染料及颜料。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
Benzyl-(3-Methyl-Isoxazol-5-Ylmethyl)-Amine · CAS 154016-55-4 · C5H8N2O.
| CAS Registry Number | 154016-55-4 |
|---|---|
| PubChem CID | 16481072 |
| Molecular formula | C5H8N2O |
| IUPAC name | (3-methyl-1,2-oxazol-5-yl)methanamine |
| Molecular Weight | 112.13 |
|---|---|
| XLogP3 | -0.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Exact Mass | 112.063662883 |
| Monoisotopic Mass | 112.063662883 |
| Topological Polar Surface Area | 52.1 |
| Heavy Atom Count | 8 |
| Formal Charge | 0 |
| Reported hazard statements | H301 (100%) |
|---|
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)
(3-METHYLISOXAZOL-5-YL)METHANAMINE; RefChem:400431; 808-816-6; 154016-55-4; 1-(3-METHYLISOXAZOL-5-YL)METHANAMINE; (3-Methylisoxazol-5-yl)methylamine; (3-methylisoxazol-5-ylmethyl)amine; (3-methyl-1,2-oxazol-5-yl)methanamine; 5-Aminomethyl-3-methylisoxazole; MFCD06738858; 5-ISOXAZOLEMETHANAMINE, 3-METHYL-; C-(3-METHYL-ISOXAZOL-5-YL)-METHYLAMINE; [(3-methylisoxazol-5-yl)methyl]amine; SCHEMBL65836; DTXSID70586129; VCA18389
CAS 154016-55-4; molecular formula C5H8N2O; molecular weight — g/mol.
(3-METHYLISOXAZOL-5-YL)METHANAMINE, RefChem:400431, 808-816-6, 154016-55-4, 1-(3-METHYLISOXAZOL-5-YL)METHANAMINE, (3-Methylisoxazol-5-yl)methylamine.
Hazard statements reported: H301.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.